Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Jagsonpal Pharmaceuticals Ltd (JGSN)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
358.80 -7.50    -2.05%
- Closed. Currency in INR ( Disclaimer )
Type:  Equity
Market:  India
ISIN:  INE048B01027 
S/N:  JAGSNPHARM
  • Volume: 49,447
  • Bid/Ask: 356.10 / 358.75
  • Day's Range: 354.65 - 374.00
Jagsonpal Pharmaceuticals 358.80 -7.50 -2.05%

Jagsonpal Pharmaceuticals Ltd Company Profile

 
Get an in-depth profile of Jagsonpal Pharmaceuticals Ltd, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

-

Equity Type

ORD

Jagsonpal Pharmaceuticals Limited engages in the manufacture and trading of pharmaceutical products and active pharmaceutical ingredients in the areas in the areas of women health, pain and analgesics, and general medicine in India and internationally. It offers pharmaceutical formulations and over the counter drugs in the areas of gynaecology, orthopaedics, and allergy management. It offers drugs in the form of tablets, softgels, injections, capsules, and syrups. The company was incorporated in 1978 and is headquartered in New Delhi, India.

Contact Information

Address T-210 J, Shahpur Jat
New Delhi, 110049
India
Phone 91 12 4440 6710
Fax 91 11 2649 4708

Top Executives

Name Age Since Title
Rajpal P. Singh Kochhar 68 2008 Chairman Emeritus
Manish Gupta 56 2022 MD & Director
Harsha Raghavan 52 2022 Non-Executive Chairman
Prithipal Singh Kochhar 44 2011 Non-Executive Director
Pallavi Dinodia Gupta 41 2022 Independent Director
Debasis Bikash Nandy 57 2022 Independent Director
Radhika Madhukar Dudhat 53 2022 Independent Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

JGSN Comments

Write your thoughts about Jagsonpal Pharmaceuticals Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Dilip Gite
Dilip Gite Dec 27, 2021 11:16PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
tp 200 for 2 months
Dilip Gite
Dilip Gite Dec 27, 2021 11:15PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
tp 200 for 2 months
Anil pura
Anil pura Apr 22, 2021 8:57PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
this is good stock it cross 10 year break out.
Narayan Yvn
Narayan Yvn Sep 11, 2019 4:45AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Atleast now can anyone suggest on this scrip..!! +20% today ?
Narayan Yvn
Narayan Yvn Aug 06, 2019 11:59PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
can anyone support on the below request..
Narayan Yvn
Narayan Yvn Feb 15, 2019 5:10AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
any one can you suggest on this stock (good/bad/sell/hold)am already holding some quantity from Long
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email